# ADMA Biologics, Inc.

Type: Company (ADMA)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/adma-biologics-inc
Canonical HTML page: https://gethealthbrief.com/entity/adma-biologics-inc

## Recent coverage (1 stories)

### Insulet’s Omnipod Defect, Embecta’s 93% Dividend Cut Spark Securities Fraud Suits
2026-07-12 01:30:53 · Sentiment: Bearish · Impact: 7/10 · Sources: 4

Medical device makers Insulet and Embecta face class actions alleging hidden defects and demand weaknesses for insulin delivery products, causing steep investor losses.
Full story: https://gethealthbrief.com/story/insulet-embecta-securities-fraud-healthcare

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.